(Q53136481)

11 May 2018

title

Leukemia risk models in primary myelofibrosis: an International Working Group study. (English)

1 reference

11 May 2018

chronic idiopathic myelofibrosis

1 reference

1 reference

1 reference

13

1 reference

11 May 2018

Ayalew Tefferi

1

object named as

A Tefferi

1 reference

11 May 2018

A Pardanani

2

1 reference

11 May 2018

N Gangat

3

1 reference

11 May 2018

K H Begna

4

1 reference

11 May 2018

C A Hanson

5

1 reference

11 May 2018

D L Van Dyke

6

1 reference

11 May 2018

D Caramazza

7

1 reference

11 May 2018

A M Vannucchi

8

1 reference

11 May 2018

E Morra

9

1 reference

11 May 2018

M Cazzola

10

1 reference

11 May 2018

A Pereira

11

1 reference

11 May 2018

F Cervantes

12

1 reference

11 May 2018

publication date

13 January 2012

1 reference

11 May 2018

published in

Leukemia

1 reference

11 May 2018

volume

26

1 reference

11 May 2018

issue

6

1 reference

11 May 2018

page(s)

1439-1441

1 reference

11 May 2018

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

Monosomal karyotype in primary myelofibrosis is detrimental to both overall and leukemia-free survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

Risk factors for leukemic transformation in patients with primary myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

Dynamic model for predicting death within 12 months in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.374

7 January 2021

Identifiers

DOI

10.1038/LEU.2011.374

1 reference

11 May 2018

1 reference

11 May 2018